TransMedics Group Inc 2023 SR
The report provides an update on TransMedics' ESG performance for 2023, focusing on its Organ Care System (OCS) and the National OCS Program (NOP). Key highlights include the launch of TransMedics Aviation to optimize organ transplant logistics and a 12% increase in heart and liver transplants enabled by OCS technology. The company expanded its workforce to 547 employees, achieved a 48.4% female representation overall, and maintained zero product recalls or fatalities. Additionally, TransMedics enhanced its governance by appointing a General Counsel and a Chief Information Officer to oversee compliance and cybersecurity programs.
Company: TransMedics Group Inc
Sector: Health Care
Country: United States
Year: 2023
Type: SR
Pages: 19
TransMedics Group Inc
ESG Data Update
The report provides an update on TransMedics' ESG performance for 2023, focusing on its Organ Care System (OCS) and the National OCS Program (NOP). Key highlights include the launch of TransMedics Aviation to optimize organ transplant logistics and a 12% increase in heart and liver transplants enabled by OCS technology. The company expanded its workforce to 547 employees, achieved a 48.4% female representation overall, and maintained zero product recalls or fatalities. Additionally, TransMedics enhanced its governance by appointing a General Counsel and a Chief Information Officer to oversee compliance and cybersecurity programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2021 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees